Enterprise Bank & Trust’s Biogen BIIB Stock Holding History

Enterprise Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$329K	Sell	2,618 -45	-2%	-$5.61K	0.12%	98
2025 Q1	$364K	Sell	2,663 -201	-7%	-$28.7K	0.14%	97
2024 Q4	$438K	Sell	2,864 -1,138	-28%	-$192K	0.14%	85
2024 Q3	$776K	Sell	4,002 -569	-12%	-$119K	0.25%	64
2024 Q2	$1.06M	Sell	4,571 -49	-1%	-$10.6K	0.36%	55
2024 Q1	$996K	Buy	4,620 +4	+0.1%	+$937	0.34%	58
2023 Q4	$1.19M	Sell	4,616 -39	-0.8%	-$9.58K	0.43%	51
2023 Q3	$1.2M	Buy	4,655 +55	+1%	+$14.7K	0.49%	46
2023 Q2	$1.31M	Buy	4,600 +203	+5%	+$60.4K	0.5%	48
2023 Q1	$1.22M	Buy	4,397 +7	+0.2%	+$1.94K	0.53%	48
2022 Q4	$1.22M	Sell	4,390 -10	-0.2%	-$2.82K	0.58%	48
2022 Q3	$1.18M	Buy	4,400 +140	+3%	+$29.7K	0.61%	47
2022 Q2	$869K	Buy	+4,260	New	+$871K	0.39%	62

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Enterprise Bank & Trust's BIIB Position: Q2 2025 in Review

Enterprise Bank & Trust reduced its Biogen (BIIB) stake by 1.7% in Q2 2025, selling an estimated $5.61K and leaving 2,618 shares worth $329K. The position accounts for 0.12% of the portfolio, ranked #98.

Enterprise Bank & Trust first reported a position in BIIB in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.31M in Q2 2023. 867 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

Enterprise Bank & Trust held 2,618 shares of Biogen worth $329K as of Q2 2025.
Enterprise Bank & Trust sold 45 Biogen shares in Q2 2025, an estimated $5.61K.
Biogen made up 0.12% of Enterprise Bank & Trust's portfolio in Q2 2025, its #98 holding.
Enterprise Bank & Trust first reported a position in Biogen in Q2 2022 and has held it in 13 quarters since.
Enterprise Bank & Trust's Biogen position peaked at $1.31M in Q2 2023.
867 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.